Nasal humoral immunity: the first line of protection against respiratory pathogens
ImmunoHorizons · 22.04.2026 · 10 (4)
DOI: 10.1093/immhor/vlaf076 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ImmunoHorizons, online erschienen am 26.04.2026. Verfasst von Lena Hansen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States. Hauptthemen laut MEDLINE: Immunity, Humoral, Nasal Cavity, Respiratory Tract Infections. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, ODCDC CDC HHS, National Institute of Allergy and Infectious Diseases Collaborative Influenza Vaccine Innovation Centers.
Abstract (Originalsprache)
The nasal cavity is the first site of infection for respiratory pathogens, and control of pathogens at this site is critical for limiting disease progression. Mucosal immunity in the respiratory tract has historically been studied in the lungs despite lung infections typically arising as a result of lack of pathogen control in the upper respiratory tract. However, the generation of vaccines to prevent infection and block transmission requires an understanding of how immune responses are generated and maintained within the nasal cavity. Recently, a concerted research effort to understand immune responses in the nasal cavity and upper respiratory tract has revealed new insight into how local immune responses are generated and help to control respiratory pathogens. Here, we discuss these recent advances and outstanding questions in our understanding of humoral immunity within the nasal cavity and upper respiratory tract.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
ORCID-Profile: Jenna J Guthmiller
Förderung
- NIH HHS
- ODCDC CDC HHS
- National Institute of Allergy and Infectious Diseases Collaborative Influenza Vaccine Innovation Centers
Zitieren
APA
Hansen, L., & Guthmiller, J. J. (2026). Nasal humoral immunity: the first line of protection against respiratory pathogens. ImmunoHorizons, 10(4). https://doi.org/10.1093/immhor/vlaf076
Vancouver
Hansen L, Guthmiller JJ. Nasal humoral immunity: the first line of protection against respiratory pathogens. ImmunoHorizons. 2026;10(4). doi:10.1093/immhor/vlaf076
BibTeX
@article{Hansen2026,
author = {Hansen, Lena and Guthmiller, Jenna J},
title = {Nasal humoral immunity: the first line of protection against respiratory pathogens},
journal = {ImmunoHorizons},
year = {2026},
volume = {10},
number = {4},
doi = {10.1093/immhor/vlaf076}
}
EUVIMED